A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma
<h4>Background</h4> Prophylactic transarterial chemoembolization (p-TACE) is frequently conducted for patients with hepatocellular carcinoma (HCC) in China, but the question of who could benefit from it remains controversial. Hence, we wanted to establish a nomogram model to identify pat...
Main Authors: | Nanping Lin, Lei Wang, Qizhen Huang, Weiping Zhou, Xiaolong Liu, Jingfeng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621457/?tool=EBI |
Similar Items
-
The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Lei Wang, et al.
Published: (2019-01-01) -
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
by: Mi Young Jeon, et al.
Published: (2019-01-01) -
The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
by: Seong Kyun Na, et al.
Published: (2018-01-01) -
Comparison of surgical resection and transarterial chemoembolization for patients with intermediate stage hepatocellular carcinoma
by: Chih-Lin Lin, et al.
Published: (2016-06-01) -
Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
by: Shuling Chen, et al.
Published: (2019-04-01)